2791 Words12 Pages

Module Title: Evidence- based practice and the community.
Assignment Title: Evidence-based learning presentation TCA1
Module Code: NS501
Module Leader: Sarah Ambrose Wilson
Module Lecturer: David Rawcliffe
Cohort: September 2013
Date: 20th April, 2015
Student ID Number: 21309385.


To discuss alcohol misuse as a public health problem; the effects on health and negative social effects to individuals, families, and society at large.

To identify and discuss public health policies on alcohol misuse in our society.

To identify and discuss some local and national initiatives on alcohol misuse in our society.

To identify and discuss nurses role and relevant health promotion to
…show more content…
Alcohol also increases the risk of developing certain cancers including liver, mouth, oesophagus, pharynx and breast, bowel and colorectal cancer.

Leon, DA, McCambridge, J. (2006)Liver cirrhosis mortality rates in Britain from 1950 to 2002: An analysis of routine data. Lancet; 367: 52-56.
Academy of Medical Sciences( 2004)Calling time: The nation 's drinking as a major health issue. London: Academy of Medical Sciences.
World Health Organization.(2003)Diet, nutrition and the prevention of chronic diseases. Geneva: WHO.

Alcohol misuse related costs, ill health and mortality
Public Health England, the Department of Health and the Health and Social Care Information Centre suggests that:

 Between 2012/13- estimated admissions related to alcohol misuse which resulted to alcohol-related diseases and injuries were 1,008,850 patients.
 65% (651,010) were chronic conditions

 6% (60,830) were acute conditions .
 65% of the overall admissions were male patients and the rest female patients.
 under 16s, females were more likely to be admitted to hospital with alcohol related diseases and injuries than males, with females accounting for 55% of all admission.
 In 2013, 183,810 items were prescribed (in a primary care setting or NHS hospital) for the treatment of alcohol dependency and dispensed in the community.
 The Net Ingredient Cost (NIC) of these prescription items in 2013 was £3.13 million, which is an increase of £0.2 million since 2012 and just over double the NIC
Get Access